PMS Registry
Company Name
Bayer Taiwan Co., Ltd.
Protocol Number
Title of Study
TAURUS: A MulTinational PhAse IV Study EvalUating “Real World” Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog alfa) for RoUtine ProphylaxiS.
Primary Objective
The primary objective of this study is to investigate weekly prophylaxis dosing regimens used
in standard clinical practice.
Number of Sites
Period of Study
From:Jun 2018  to:Jan 2020
Number of Patients
IRB Approval Date
Taipei Veterans General Hospital: 24May2018
Taichung Veterans General Hospital: 5Jun2018
Kaohsiung Medical University Chung-Ho Memorial Hospital: 8Jun2018
China Medical University Hospital: 26May2018
Pingtung Christian Hospital : 4Jul2018
Publication Plan / Date